Citation 90548

LIN,WY: KUO,YH: CHANG,YL: TENG,CM: WANG,EC: ISHIKAWA,T: CHEN,IS:. (2003). ANTI-PLATELET AGGREGATION AND CHEMICAL CONSTITUENTS FROM THE RHIZOME OF GYNURA JAPONICA.. 69(8)

Citation Details

Title	ANTI-PLATELET AGGREGATION AND CHEMICAL CONSTITUENTS FROM THE RHIZOME OF GYNURA JAPONICA.
Authors	LIN,WY: KUO,YH: CHANG,YL: TENG,CM: WANG,EC: ISHIKAWA,T: CHEN,IS:
Year	2003
Volume	69
Issue	8

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Gynura japonica (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	WEAK ACTIVITY
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	WEAK ACTIVITY
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	WEAK ACTIVITY
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TOCOSPIRONE,ALPHA: (-):	None
6	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	GYNURAONE,(-):	None
7	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GYNURAONE,(-):	WEAK ACTIVITY
8	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GYNURAONE,(-):	WEAK ACTIVITY
9	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GYNURAONE,(-):	WEAK ACTIVITY
10	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STIGMASTA-5-TRANS-22-DIEN-3-BETA-OL,7-ALPHA-HYDROPEROXY: 24(S):	None
11	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTA-5-TRANS-22-DIEN-3-BETA-OL,7-ALPHA-HYDROPEROXY: 24(S):	ACTIVE
12	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTA-5-TRANS-22-DIEN-3-BETA-OL,7-ALPHA-HYDROPEROXY: 24(S):	ACTIVE
13	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTA-5-TRANS-22-DIEN-3-BETA-OL,7-ALPHA-HYDROPEROXY: 24(S):	ACTIVE
14	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STIGMASTA-1-4-TRANS-22-TRIEN-3-ONE,24(S):	None
15	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTA-1-4-TRANS-22-TRIEN-3-ONE,24(S):	WEAK ACTIVITY
16	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTA-1-4-TRANS-22-TRIEN-3-ONE,24(S):	WEAK ACTIVITY
17	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTA-1-4-TRANS-22-TRIEN-3-ONE,24(S):	WEAK ACTIVITY
18	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STIGMASTA-1-4-DIEN-3-ONE,TRANS-22: 24(R):	None
19	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTA-1-4-DIEN-3-ONE,TRANS-22: 24(R):	WEAK ACTIVITY
20	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTA-1-4-DIEN-3-ONE,TRANS-22: 24(R):	WEAK ACTIVITY
21	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTA-1-4-DIEN-3-ONE,TRANS-22: 24(R):	WEAK ACTIVITY
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CARYOPHYLLENE OXIDE	None
23	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARYOPHYLLENE OXIDE	ACTIVE
24	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARYOPHYLLENE OXIDE	ACTIVE
25	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARYOPHYLLENE OXIDE	ACTIVE
26	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTA-5-22-DIEN-3-BETA-OL,7-ALPHA-HYDROPEROXY: 24(R):	None
27	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTERONE,TRANS-22:	None
28	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTERONE,TRANS-22:	WEAK ACTIVITY
29	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTERONE,TRANS-22:	WEAK ACTIVITY
30	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTERONE,TRANS-22:	WEAK ACTIVITY
31	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SITOSTERONE,BETA:	None
32	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTERONE,BETA:	WEAK ACTIVITY
33	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTERONE,BETA:	WEAK ACTIVITY
34	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTERONE,BETA:	WEAK ACTIVITY
35	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHROMAN-4-ONE,6-ACETYL-2-2-DIMETHYL:	None
36	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMAN-4-ONE,6-ACETYL-2-2-DIMETHYL:	ACTIVE
37	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMAN-4-ONE,6-ACETYL-2-2-DIMETHYL:	ACTIVE
38	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMAN-4-ONE,6-ACETYL-2-2-DIMETHYL:	ACTIVE
39	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	VANILLIN	None
40	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN	ACTIVE
41	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN	ACTIVE
42	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN	ACTIVE
43	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTEROL	None
44	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTEROL	WEAK ACTIVITY
45	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTEROL	WEAK ACTIVITY
46	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTEROL	WEAK ACTIVITY
47	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SITOSTEROL,BETA:	None
48	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	WEAK ACTIVITY
49	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	WEAK ACTIVITY
50	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	WEAK ACTIVITY
51	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HEXACOSANOIC ACID	None
52	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEXACOSANOIC ACID	ACTIVE
53	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEXACOSANOIC ACID	ACTIVE
54	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEXACOSANOIC ACID	ACTIVE
55	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BENZOQUINONE,1-4: 2-6-DIMETHOXY:	None
56	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOQUINONE,1-4: 2-6-DIMETHOXY:	ACTIVE
57	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOQUINONE,1-4: 2-6-DIMETHOXY:	ACTIVE
58	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOQUINONE,1-4: 2-6-DIMETHOXY:	ACTIVE
59	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PALMITIC ACID	None
60	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMITIC ACID	WEAK ACTIVITY
61	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMITIC ACID	WEAK ACTIVITY
62	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMITIC ACID	WEAK ACTIVITY
63	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHROMAN-4-ONE,6-ACETYL-2-HYDROXY-METHYL-2-METHYL:	None
64	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMAN-4-ONE,6-ACETYL-2-HYDROXY-METHYL-2-METHYL:	WEAK ACTIVITY
65	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMAN-4-ONE,6-ACETYL-2-HYDROXY-METHYL-2-METHYL:	WEAK ACTIVITY
66	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMAN-4-ONE,6-ACETYL-2-HYDROXY-METHYL-2-METHYL:	WEAK ACTIVITY
67	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BENZOIC ACID	None
68	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOIC ACID	WEAK ACTIVITY
69	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOIC ACID	WEAK ACTIVITY
70	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOIC ACID	WEAK ACTIVITY
71	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTEROL-3-O-BETA-D-GLUCOPYRANOSIDE	None
72	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTEROL-3-O-BETA-D-GLUCOPYRANOSIDE	WEAK ACTIVITY
73	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTEROL-3-O-BETA-D-GLUCOPYRANOSIDE	WEAK ACTIVITY
74	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTEROL-3-O-BETA-D-GLUCOPYRANOSIDE	WEAK ACTIVITY
75	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DAUCOSTEROL	None
76	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAUCOSTEROL	WEAK ACTIVITY
77	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAUCOSTEROL	WEAK ACTIVITY
78	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAUCOSTEROL	WEAK ACTIVITY

Citation 90548

Citation Details

Summary

Organisms and Their Experiments (1)

Gynura japonica (ASTERACEAE)

Show SPARQL Queries (1)

Query 1